Latest News

FDA approves COVID-19 vaccine for everyone 16+

By Estela Balderas | August 23, 2021

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization…

READ MORE

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

By Estela Balderas | August 23, 2021

August 18, 2021: The Panel updated the following section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the section are summarized below: Human Papillomavirus Disease:New recommendation for cervical cancer screening to start at age 21 based on the HIV/AIDS Cancer Match Study with no…

READ MORE

Ohio Department of Health Releases Health Alert: Increase in Cases of Congenital Syphilis

By Estela Balderas | August 17, 2021

On July 15, 2021, the Ohio Department of Health (ODH) issued a health alert regarding a rise in the number of cases of congenital syphilis (CS). Since 2016, CS in Ohio has increased 146% from 13 cases in 2016 to 32 cases in 2020. CS occurs when the sexually transmitted pathogen treponema pallidum infects a…

READ MORE

COVID-19 Vaccines for Moderately to Severely Immunocompromised People

By Estela Balderas | August 17, 2021

CDC now recommends that people whose immune systems are compromised moderately to severely should receive an additional dose of mRNA COVID-19 vaccine after the initial 2 doses. Widespread vaccination is a critical tool to help stop the pandemic. Read CDC’s statement. What You Need to Know People who are moderately to severely immunocompromised are especially vulnerable to COVID-19…

READ MORE

Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

By Estela Balderas | August 17, 2021

August 16, 2021: The Panel updated the Hepatitis C Virus / HIV Co-infection section of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV.

READ MORE

HHS Adult and Adolescent Opportunistic Infections Guidelines Updated

By Estela Balderas | July 2, 2021

The following two sections of the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated: Candidiasis (Mucocutaneous): The Panel updated the text, treatment, pregnancy considerations, references, and treatment table and made the following key changes: • Added important new information on spontaneous abortion in pregnant women after any exposure…

READ MORE

HHS HIV/AIDS Guidelines Panels Release Interim Guidance for COVID-19 and Persons with HIV

By Estela Balderas | March 8, 2021

The Interim Guidance for COVID-19 and Persons with HIV is now available on the AIDSinfo website. The guidance, which was developed collectively by the U.S. Department of Health and Human Services (HHS) Antiretroviral and Opportunistic Infections Guidelines Panels, which are working groups of the Office of AIDS Research Advisory Council, is intended for health care providers and…

READ MORE

New Illinois Medicaid Prescription Drug Policy Coming January 1, 2020

By Estela Balderas | March 8, 2021

Do you have patients, friends or clients who are on Medicaid? If the answer is “yes,” keep reading the important information below! On Jan. 1, 2020, prescription drug coverage is changing for Illinois Medicaid.Previously, Medicaid managed care plans covered whatever drugs they wanted. Starting in January, every plan in the state will have to cover…

READ MORE

CONNECT WITH US

MATEC Regional Headquarters
University of Illinois at Chicago, College of Medicine
Department of Family and Community Medicine
1919 W. Taylor Street (MC779), 8th Floor
Chicago IL 60612